Voting Rights and Shares Capital of the Company
PARIS, Dec. 08, 2022 (GLOBE NEWSWIRE) --
- (1) The total number of theoretical (or “gross”) voting rights is used as the basis for calculating threshold crossings.
- In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.
- (2)The total number of exercisable at a Shareholders’ Meeting (or “net”) voting rights is calculated without taking into account shares for which voting rights have been suspended as shares held in treasury by the Company.
- Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity.